{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:46:14Z","timestamp":1761237974011},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T00:00:00Z","timestamp":1361232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s00044-013-0528-1","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T10:19:03Z","timestamp":1361269143000},"page":"5344-5348","source":"Crossref","is-referenced-by-count":9,"title":["Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B"],"prefix":"10.1007","volume":"22","author":[{"given":"Girdhar Singh","family":"Deora","sequence":"first","affiliation":[]},{"given":"Chandrabose","family":"Karthikeyan","sequence":"additional","affiliation":[]},{"given":"N. S. Hari Narayana","family":"Moorthy","sequence":"additional","affiliation":[]},{"given":"Vandana","family":"Rathore","sequence":"additional","affiliation":[]},{"given":"Arun K.","family":"Rawat","sequence":"additional","affiliation":[]},{"given":"Akhilesh K.","family":"Tamrakar","sequence":"additional","affiliation":[]},{"given":"A. K.","family":"Srivastava","sequence":"additional","affiliation":[]},{"given":"Piyush","family":"Trivedi","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,2,19]]},"reference":[{"key":"528_CR1","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1016\/j.bmcl.2009.09.020","volume":"19","author":"BR Bhattarai","year":"2009","unstructured":"Bhattarai BR, Kafle B, Hwang JS, Khadka D, Lee SM, Kang JS, Ham SW, Han IO, Park H, Cho H (2009) Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects. Bioorg Med Chem Lett 19:6161\u20136165","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejphar.2003.11.070","volume":"485","author":"HG Cheon","year":"2004","unstructured":"Cheon HG, Kim SM, Yang SD, Ha JD, Choi JK (2004) Discovery of a novel protein tyrosine phosphatase-1B inhibitor, KR61639: potential development as an antihyperglycemic agent. Eur J Pharmacol 485:333\u2013339","journal-title":"Eur J Pharmacol"},{"key":"528_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bmcl.2005.10.062","volume":"16","author":"SY Cho","year":"2006","unstructured":"Cho SY, Baek JY, Han SS, Kang SK, Ha JD, Ahn JH, Lee JD, Kim KR, Cheon HG, Rhee SD, Yang SD, Yon GH, Pak CS, Choi JK (2006) PTP1B inhibitors: Cyclopenta[d][1,2]-oxazine derivatives. Bioorg Med Chem Lett 16:499\u2013502","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bmc.2006.10.053","volume":"15","author":"M Dixit","year":"2007","unstructured":"Dixit M, Tripathi BK, Tamrakar AK, Srivastava AK, Kumar B, Goel A (2007) Synthesis of benzofuran scaffold-based potential PTP1B inhibitors. Bioorg Med Chem 15:727\u2013734","journal-title":"Bioorg Med Chem"},{"key":"528_CR5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bmcl.2007.11.012","volume":"18","author":"B Douty","year":"2008","unstructured":"Douty B, Wayland B, Ala PJ, Bower MJ, Pruitt J, Bostrom L, Wei M, Klabe R, Gonneville L, Wynn R, Burn TC, Liu PCC, Combs AP, Yue EW (2008) Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines. Bioorg Med Chem Lett 18:66\u201371","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.diabres.2010.01.024","volume":"87","author":"LE Egede","year":"2010","unstructured":"Egede LE, Ellis C (2010) Diabetes and depression: global perspectives. Diabetes Res Clin Pract 87:302\u2013312","journal-title":"Diabetes Res Clin Pract"},{"key":"528_CR7","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.bmc.2009.02.060","volume":"17","author":"M Forghieri","year":"2009","unstructured":"Forghieri M, Laggner C, Paoli P, Langer T, Manao G, Camici G, Bondioli L, Prati F, Costantino L (2009) Synthesis, activity and molecular modeling of a new series of chromones as low molecular weight protein tyrosine phosphatase inhibitors. Bioorg Med Chem Lett 17:2658\u20132672","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nrd895","volume":"1","author":"TO Johnson","year":"2002","unstructured":"Johnson TO, Ermolieff J, Jirousek MR (2002) Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 1:696\u2013709","journal-title":"Nat Rev Drug Discov"},{"key":"528_CR9","author":"P Joshi","year":"2012","unstructured":"Joshi P, Deora GS, Rathore V, Tanwar OP, Rawat AK, Srivastava AK, Jain D (2012a) Identification of ZINC02765569: a potent inhibitor of PTP1B by vHTS. Med Chem Res. doi: 10.1007\/s00044-012-0007-0","journal-title":"Med Chem Res"},{"key":"528_CR10","author":"P Joshi","year":"2012","unstructured":"Joshi P, Deora GS, Rathore V, Rawat AK, Srivastava AK, Jain D (2012b) Molecular modeling and synthesis of ZINC02765569 derivatives as protein tyrosine phosphatase 1B inhibitors: lead optimization study. Med Chem Res. doi: 10.1007\/s00044-012-0165-0","journal-title":"Med Chem Res"},{"key":"528_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5012\/bkcs.2011.32.1.31","volume":"32","author":"B Kafle","year":"2011","unstructured":"Kafle B, Bhattarai BR, Cho H (2011) Barbituric acid derivatives as protein tyrosine phosphatase inhibitors. Bull Korean Chem Soc 32:31\u201332","journal-title":"Bull Korean Chem Soc"},{"key":"528_CR12","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1016\/j.bmcl.2007.05.081","volume":"17","author":"R Kumar","year":"2007","unstructured":"Kumar R, Mittal A, Ramachandran U (2007) Design and synthesis of 6-methyl-2-oxo-1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid derivatives as PPAR\u03b3 activators. Bioorg Med Chem Lett 17:4613\u20134618","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR13","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/S0968-0896(02)00176-1","volume":"10","author":"C Liljebris","year":"2002","unstructured":"Liljebris C, Martinsson J, Tedenborg L, Williams M, Barker E, Duffy JES, Nygren A, James S (2002) Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B). Bioorg Med Chem Lett 10:3197\u20133212","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR14","unstructured":"Maestro (2011) version 9.2, Schr\u00f6dinger, LLC, New York, NY"},{"key":"528_CR15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0014-5793(03)00603-3","volume":"546","author":"K Nicholas","year":"2003","unstructured":"Nicholas K (2003) PTP1B: from the sidelines to the front lines! FEBS Lett 546:140\u2013148","journal-title":"FEBS Lett"},{"key":"528_CR16","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1016\/S0960-894X(03)00725-X","volume":"13","author":"Z Pei","year":"2003","unstructured":"Pei Z, Li X, Liu G, Bad-Zapatero C, Lubben T, Zhang T, Ballaron SJ, Hutchins CW, Trevillyan JM, Jirousek MR (2003) Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett 13:3129\u20133132","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR17","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.94.25.13420","volume":"94","author":"YA Puius","year":"1997","unstructured":"Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY (1997) Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. Proc Natl Acad Sci 94:13420\u201313425","journal-title":"Proc Natl Acad Sci"},{"key":"528_CR18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4\u201314","journal-title":"Diabetes Res Clin Pract"},{"key":"528_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0168-8227(02)00275-9","volume":"59","author":"RW Simpson","year":"2003","unstructured":"Simpson RW, Shaw JE, Zimmet PZ (2003) The prevention of type 2 diabetes\u2014lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract 59:165\u2013180","journal-title":"Diabetes Res Clin Pract"},{"key":"528_CR20","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1016\/j.bmcl.2006.06.051","volume":"16","author":"ZK Wan","year":"2006","unstructured":"Wan ZK, Lee J, Xu W, Erbe DV, Joseph-McCarthy D, Follows BC, Zhang YL (2006) Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48. Bioorg Med Chem Lett 16:4941\u20134945","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR21","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1016\/j.bmcl.2003.08.064","volume":"13","author":"Z Xin","year":"2003","unstructured":"Xin Z, Liu G, Bad-Zapatero C, Pei Z, Szczepankiewicz BG, Li X, Zhang T, Hutchins CW, Hajduk PJ, Ballaron SJ, Stashko MA, Lubben TH, Trevillyan JM, Jirousek MR (2003) Identification of a monoacid-Based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13:3947\u20133950","journal-title":"Bioorg Med Chem Lett"},{"key":"528_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3797\/scipharm.0803-10","volume":"76","author":"A Zarghi","year":"2008","unstructured":"Zarghi A, Hamedi S, Tootooni F, Amini B, Sharifi B, Faizi M, Abbas Tabatabai S, Shafiee A (2008) Synthesis and pharmacological evaluation of new 2-substituted-5-{2-[(2-halobenzyl)thio)phenyl}-1,3,4-oxadiazoles as anticonvulsant agents. Sci Pharm 76:185\u2013201","journal-title":"Sci Pharm"},{"key":"528_CR23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","volume":"87","author":"P Zhang","year":"2010","unstructured":"Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:293\u2013301","journal-title":"Diabetes Res Clin Pract"},{"key":"528_CR24","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1016\/j.bmcl.2004.08.063","volume":"14","author":"H Zhao","year":"2004","unstructured":"Zhao H, Liu G, Xin Z, Serby MD, Pei Z, Szczepankiewicz BG, Hajduk PJ, Bad-Zapatero C, Hutchins CW, Lubben TH, Ballaron SJ, Haasch DL, Kaszubska W, Rondinone CM, Trevillyan JM, Jirousek MR (2004) Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Bioorg Med Chem Lett 14:5543\u20135546","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-013-0528-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00044-013-0528-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-013-0528-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T15:34:43Z","timestamp":1558539283000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00044-013-0528-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,19]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["528"],"URL":"https:\/\/doi.org\/10.1007\/s00044-013-0528-1","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,19]]}}}